Ng, Andrew H.
Nguyen, Taylor H.
Gómez-Schiavon, Mariana
Dods, Galen
Langan, Robert A.
Boyken, Scott E.
Samson, Jennifer A.
Waldburger, Lucas M.
Dueber, John E.
Baker, David
El-Samad, Hana
Article History
Received: 17 April 2019
Accepted: 11 June 2019
First Online: 24 July 2019
Change Date: 25 February 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: R.A.L., A.H.N., S.E.B., D.B. and H.E.-S. have filed a provisional patent application describing the design, composition and function of degronLOCKR constructs. R.A.L., A.H.N., S.E.B., D.B. and H.E.-S. have filed a provisional patent application describing the degronLOCKR-based molecular feedback circuits. D.B. and S.E.B. hold equity in Lyell Immunopharma.